21 12, 2016

Problems for breast cancer researchers in 2017?

By | December 21st, 2016|Categories: "Experimental design controls etc", Other stuff|1 Comment

Breast cancer researchers publish a lot of papers, and a large number of those will include some genomics, variant identification, RNA-Seq, ChIP-Seq, etc. Increasingly research is being carried out on patient derived material, but cell lines are still a vital part of much of the […]

15 12, 2016

The 5 hardest things about single-cell sequencing

By | December 15th, 2016|Categories: Next-generation sequencing, Single-cell sequencing|2 Comments

Single-cell sequencing is making waves with many exciting developments over the last couple of years. Hardware is available from the companies like 10X Genomics, Fluidigm, Wafergen, BioRad (see GenomeWeb), RainDance (see GenomeWeb), Dolomite Bio. Chemistry for RNA and Genome sequencing such as SMART-Seq V4 and TruPrime, opens up all sorts […]

13 12, 2016

Oxford Nanopore – a billion dollar valuation!

By | December 13th, 2016|Categories: Next-generation sequencing|0 Comments

The latest round of fundraising by ONT brought in over $100 million, that makes a total of around $X million invested over the last X years. This round of funding was led by GT Healthcare, a Hong Kong based investment group. According to the Financial Times […]

11 12, 2016

The new sequencer from Qiagen

By | December 11th, 2016|Categories: Next-generation sequencing|0 Comments

Qiagen are now finally selling the GeneReader after a hiatus of several years. This was caused by issues getting a working instrument out of the original IBS technology, and also held, temporarily, up by recent Illumina litigation. GenomeWeb covered the relaunch back in November. Qiagens updated […]

21 10, 2016

Does the world have too many HiSeq X Tens?

By | October 21st, 2016|Categories: Next-generation sequencing|6 Comments

Illumina stock dropped 25% after a hammering by the stock market with their recent announcements that Q3 revenues would be 3.4% lower than expected at just $607 million. This makes Illumina a much more attractive acquisition (although I doubt this summers rumours of a Thermo […]

Load More Posts